Xiao W - Search Results

1

Non-targeted metabolomic analysis predicts the therapeutic effects of exenatide on endothelial injury in patients with type 2 diabetes.

Yang J, Le Y, Wei T, Wang K, Yang K, Xiao W, Hong T, Wei R. Yang J, et al. Among authors: xiao w. J Diabetes Complications. 2021 Feb;35(2):107797. doi: 10.1016/j.jdiacomp.2020.107797. Epub 2020 Nov 26. J Diabetes Complications. 2021. PMID: 33293208

2

GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.

Liu J, Yang K, Xiao W, Le Y, Lang S, Zhang J, Wei R, Yang J, Hong T. Liu J, et al. Among authors: xiao w. Peptides. 2018 Aug;106:83-90. doi: 10.1016/j.peptides.2018.07.001. Epub 2018 Jul 9. Peptides. 2018. PMID: 30003931 Clinical Trial.

3

Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.

Liu J, Yang K, Yang J, Xiao W, Le Y, Yu F, Gu L, Lang S, Tian Q, Jin T, Wei R, Hong T. Liu J, et al. Among authors: xiao w. EBioMedicine. 2019 Mar;41:73-84. doi: 10.1016/j.ebiom.2019.02.037. Epub 2019 Mar 1. EBioMedicine. 2019. PMID: 30827929 Free PMC article. Clinical Trial.

4

Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.

Yang J, Xiao W, Guo L, Li Q, Zhong L, Yang J, Yang J, Gao Y, Tian Q, Hong T. Yang J, et al. Among authors: xiao w. Acta Diabetol. 2020 Aug;57(8):991-1000. doi: 10.1007/s00592-020-01510-y. Epub 2020 Mar 23. Acta Diabetol. 2020. PMID: 32206903 Clinical Trial.

5

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.

Yang K, Wang H, Wei R, Xiao W, Tian Q, Wang C, Yang J, Hong T. Yang K, et al. Among authors: xiao w. Acta Diabetol. 2021 May;58(5):595-602. doi: 10.1007/s00592-020-01660-z. Epub 2021 Jan 15. Acta Diabetol. 2021. PMID: 33452595 Clinical Trial.

6

Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide.

Le Y, Yang K, Yang J, Fu W, Xiao W, Wei R, Hong T. Le Y, et al. Among authors: xiao w. Diabetes Ther. 2022 Oct;13(10):1755-1767. doi: 10.1007/s13300-022-01310-3. Epub 2022 Aug 13. Diabetes Ther. 2022. PMID: 35963931 Free PMC article.

7

Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19.

Liu Y, Lu R, Wang J, Cheng Q, Zhang R, Zhang S, Le Y, Wang H, Xiao W, Gao H, Zeng L, Hong T. Liu Y, et al. Among authors: xiao w. BMC Endocr Disord. 2021 Mar 26;21(1):56. doi: 10.1186/s12902-021-00717-6. BMC Endocr Disord. 2021. PMID: 33771154 Free PMC article.

8

[Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus].

Zhang JP, Yang WY, Hong TP, Yang JK, Xiao WH, Gao HW, Yang Y. Zhang JP, et al. Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1238-40. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17686255 Clinical Trial. Chinese.

9

The effects of pioglitazone on biochemical markers of bone turnover in the patients with type 2 diabetes.

Xiao WH, Wang YR, Hou WF, Xie C, Wang HN, Hong TP, Gao HW. Xiao WH, et al. Int J Endocrinol. 2013;2013:290734. doi: 10.1155/2013/290734. Epub 2013 Jun 16. Int J Endocrinol. 2013. PMID: 23843787 Free PMC article.

10

Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis.

Liu Z, Wang H, Xiao W, Wang C, Liu G, Hong T. Liu Z, et al. Among authors: xiao w. Int J Exp Pathol. 2010 Oct;91(5):420-5. doi: 10.1111/j.1365-2613.2010.00715.x. Int J Exp Pathol. 2010. PMID: 20586818 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,409 results

Search Page

Filters